Attached files

file filename
8-K/A - FORM 8-K/A - BALLANTYNE STRONG, INC.btn20131209_8ka.htm
EX-23 - EXHIBIT 23.1 - BALLANTYNE STRONG, INC.ex23-1.htm
EX-99 - EXHIBIT 99.2 - BALLANTYNE STRONG, INC.ex99-2.htm
EX-99 - EXHIBIT 99.3 - BALLANTYNE STRONG, INC.ex99-3.htm

EXHIBIT 99.4

 

 

 

 

 

 

 

 

Unaudited Pro Forma Condensed Consolidated Financial Information

 

 

On October 1, 2013, Ballantyne Strong, Inc. (“the Company” or “Ballantyne”) acquired all of the issued and outstanding shares of the capital stock of Convergent Corporation (“Convergent”).  At the closing of the acquisition, Ballantyne paid a total of $17.4 million, adjusted for Convergent’s cash on hand in Canada and working capital variance from targeted working capital. 

 

The unaudited pro forma condensed consolidated financial information is based on the historical consolidated financial information of Ballantyne and Convergent and has been prepared to present the impact of the acquisition.

 

The unaudited pro forma condensed consolidated financial information is provided for informational purposes only. The unaudited pro forma condensed consolidated financial information is not necessarily indicative of operating results that would have been achieved had the acquisition been completed as of January 1, 2012 and does not intend to project the future financial results of Ballantyne after the acquisition of Convergent. The unaudited pro forma condensed consolidated balance sheet does not purport to reflect what our financial condition would have been had the transaction closed on September 30, 2013 or for any future or historical period. The unaudited pro forma condensed consolidated statements of operations and balance sheet do not reflect the cost of any integration activities or benefits from the acquisition and synergies that may be derived.

 

Ballantyne’s fiscal year ends in December, while Convergent’s ends in March. The unaudited pro forma condensed consolidated balance sheet combines the interim unaudited consolidated balance sheet of Ballantyne and Convergent as of September 30, 2013. The full-year unaudited pro forma condensed consolidated statement of operations for the year ended December 31, 2012 combines the statement of operations of Ballantyne for the fiscal year ended December 31, 2012 with the statements of operations of Convergent for the full year ended December 31, 2012. The full-year unaudited condensed consolidated statement of operations for Convergent was determined by adding the unaudited statement of operations for the three months ended March 31, 2012 to the statement of operations for Convergent’s fiscal year ended March 31, 2013, and subtracting Convergent’s unaudited statement of operations for the three months ended March 31, 2013. The interim unaudited pro forma condensed consolidated statement of operations for the nine months ended September 30, 2013 combines the unaudited statement of operations of Ballantyne for the nine months ended September 30, 2013 and the unaudited statement of operations of Convergent for the nine months ended September 30, 2013.

 

This information should be read in conjunction with (i) the accompanying notes to the unaudited pro forma condensed consolidated financial information, (ii) Ballantyne’s Current Report on Form 8-K filed October 3, 2013, including the exhibits thereto, (iii) Audited financial statements of Ballantyne as of and for the year ended December 31, 2012, which are included in Ballantyne’s Annual Report on Form 10-K for the year ended December 31, 2012, as filed with the SEC, (iv) Unaudited interim financial statements of Ballantyne included in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2013 as filed with the SEC, (v) Convergent’s audited financial statements as of March 31, 2013 and the year then ended, included as Exhibit 99.2 in this Current Report on Form 8-K/A, and (vi) Convergent’s unaudited interim financial statements for the six month periods ended September 30, 2013 and 2012 included in this Current Report on Form 8-K/A.

 

 
 

 

 

Ballantyne Strong, Inc. and Subsidiaries

Unaudited Pro Forma Condensed Consolidated Balance Sheet

September 30, 2013
(In thousands)

 

   

Ballantyne
Strong, Inc.
September 30,
2013

   

Convergent

Corporation

September 30,
2013

   



Pro Forma

Adjustments

 



Note
Ref

 

Pro Forma
Consolidated
September

30, 2013

 
                                   

Assets

                                 

Current assets:

                                 

Cash and cash equivalents

  $ 26,333     $ 358     $ (588

)

3(a), 3(i)

  $ 26,103  

Accounts receivable, net

    12,404       3,046                 15,450  

Sales type lease receivable

    -       1,918       (136

3(b) 

    1,782  

Inventories

    13,885       4,127        

 

      18,012  

Deposit on Convergent acquisition

    17,424       -       (17,424

)

3(e)

    -  

Other current assets

    4,131       2,112       (806

)

3(d), 3(h)

    5,437  

Total current assets

    74,177       11,561       (18,954

)

      66,784  

Property, plant and equipment, net of accumulated depreciation

    10,149       4,467       462

 

3(c)

    15,078  

Note receivable

    2,388       -                 2,388  

Goodwill

    1,163       -       77  

3(f)

    1,240  

Intangibles other than goodwill

    635       909       258  

3(g)

    1,802  

Sales type lease receivable

    -       3,337        (101 3(b)      3,236  

Other assets

    2,172       428       (263 )

3(h)

    2,337  

Total assets

  $ 90,684     $ 20,702     $ (18,521

)

    $ 92,865  

Liabilities and Stockholders’ Equity

                                 

Current liabilities:

                                 

Accounts payable

  $ 9,028     $ 1,045     $ (485

)

3(i)

  $ 9,588  

Accrued expenses

    4,520       687                 5,207  

Income taxes payable

    57       -                 57  

Customer deposits/deferred revenue

    2,726       1,002       (174

)

3(j)

    3,554  

Total current liabilities

    16,331       2,734       (659

)

      18,406  

Deferred revenue

    3,081       172                 3,253  

Deferred income taxes

    816       -                 816  

Payable to related party

    -       11,459       (11,459

)

3(k)

    -  

Other accrued expenses, net of current portion

    1,821       -       -         1,821  

Total liabilities

    22,049       14,365       (12,118

)

      24,296  

Commitments and contingencies

                                 

Stockholders’ equity:

                                 

Preferred stock

    -       -       -         -  

Common stock

    167       1       (1

)

3(l)

    167  

Additional paid-in capital

    38,116       6,344       (6,344

)

3(l)

    38,116  

Accumulated other comprehensive income

    (241

)

    70       (70

)

3(l)

    (241

)

Retained earnings (deficit)

    48,832       (78     12

 

3(l)

    48,766  

Stockholders’ equity before treasury stock

    86,874       6,337       (6,403

)

      86,808  

Less common shares in treasury, at cost

    (18,239

)

    -                 (18,239

)

Total stockholders’ equity

    68,635       6,337       (6,403

)

      68,569  

Total liabilities and stockholders’ equity

  $ 90,684     $ 20,702     $ (18,521

)

    $ 92,865  

 

  

See accompanying notes to pro forma condensed consolidated financial statements.

 

 
 

 

 

Ballantyne Strong, Inc. and Subsidiaries
Unaudited Pro Forma Condensed Consolidated Statement of Operations

Twelve Months Ended December 31, 2012

(In thousands, except per share data)

 

 

   

Ballantyne
Strong, Inc.

Year Ended

December 31, 2012

   

Convergent

Corporation

Twelve months

Ended
December 31, 2012

   

Pro Forma

Adjustments

 


 

 

Note
Ref

 

Pro Forma

Consolidation

Twelve Months

Ended
December 31, 2012

 
                                   

Net revenues

  $ 169,084     $ 41,933     $ 621  

3(m)

  $ 211,638  

Cost of revenues

    146,490       29,728       6,198  

3(m), 3(n)

    182,416  

Gross profit

    22,594       12,205       (5,577

)

      29,222  

Selling and administrative expenses:

                                 

Selling

    4,467       -       2,745  

3(o)

    7,212  

Administrative

    11,456       13,221       (7,818

)

3(n), 3(o), 3(q)

    16,859  

Depreciation and amortization

    -       429       (429

)

3(q)

    -  

Total selling and administrative expenses

    15,923       13,650       (5,502

)

      24,071  

Gain (loss) on the sale/disposal/transfer of assets

    1,332       -                 1,332  

Income (loss) from operations

    8,003       (1,445

)

    (75

)

      6,483  

Interest, net

            177                 177  

Equity income of joint venture

    10       -                 10  

Other income, net

    137       -                 137  

Income (loss) before income taxes

    8,150       (1,268

)

    (75

)

      6,807  

Income tax (expense)benefit

    (2,608

)

    417       28  

3(r)

    (2,163

)

Net earnings (loss)

  $ 5,542     $ (851

)

  $ (47

)

    $ 4,644  

Basic earnings per share

  $ 0.39                       $ 0.33  

Diluted earnings per share

  $ 0.39                       $ 0.33  
                                   

Weighted average shares outstanding

                                 

Basic

    14,038                         14,038  

Diluted

    14,115                         14,115  

 

 

See accompanying notes to pro forma condensed consolidated financial statements.

 

 
 

 

 

Ballantyne Strong, Inc. and Subsidiaries
Unaudited Pro Forma Condensed Consolidated Statement of Operations

Nine months Ended September 30, 2013

(In thousands, except per share data)

 

 

   

Ballantyne
Strong, Inc.

Nine Months Ended September 30, 2013

   

Convergent

Corporation Nine

Months Ended

September 30, 2013

   

Pro Forma

Adjustments

 

Note
Ref

 

Pro Forma

Consolidation Nine

Months Ended

September 30, 2013

 

Net revenues

  $ 70,865     $ 25,567     $ 466  

3(m)

  $ 96,898  

Cost of revenues

    58,934       19,349       2,803  

3(m), 3(n)

    81,086  

Gross profit

    11,931       6,218       (2,337

)

      15,812  

Selling and administrative expenses:

                                 

Selling

    2,586       -       1,094  

3(o)

    3,680  

Administrative

    7,478       7,310       (3,404

)

3(n), 3(o), 3(p), 3(q) 

    11,384  

Depreciation and amortization

    -       422       (422

)

3(q)

    -  

Total selling and administrative expenses

    10,064       7,732       (2,732

)

      15,064  

Gain (loss) on the sale/disposal/transfer of assets

    7       1       -         8  

Income (loss) from operations

    1,874       (1,513

)

    395         756  

Interest income,net

    169       183                 352  

Equity income of joint venture

    (117

)

    -       -         (117

)

Other income, net

    463       -       -         463  

Income (loss) before income taxes

    2,389       (1,330

)

    395         1,454  

Income tax (expense) benefit

    (502

)

    435       (144

)

3(r)

    (211

)

Net earnings (loss)

  $ 1,887     $ (895

)

  $ 251       $ 1,243  

Basic earnings per share

  $ 0.13                       $ 0.09  

Diluted earnings per share

  $ 0.13                       $ 0.09  
                                   

Weighted average shares outstanding:

                                 

Basic

    13,995                         13,995  

Diluted

    14,025                         14,025  

 

 

See accompanying notes to pro forma condensed consolidated financial statements.

 

 
 

 

 

Ballantyne Strong, Inc. and Subsidiaries

Notes to the Pro Forma Condensed Consolidated Financial Statements

(Unaudited)

 

1.

Basis of Presentation

 

The unaudited pro forma condensed consolidated financial information is based on the historical consolidated financial information of Ballantyne and Convergent. The unaudited pro forma condensed consolidated balance sheet as of September 30, 2013 assumes Ballantyne’s acquisition of Convergent was completed on that date. The unaudited pro forma condensed consolidated statements of operations for the year ended December 31, 2012 and the nine months ended September 30, 2013 assume Ballanytne’s acquisition of Convergent was completed on January 1, 2012.

 

Pro forma adjustments reflected in the unaudited pro forma condensed consolidated balance sheet are based on items that are directly attributable to Ballantyne’s acquisition of Convergent and that are factually supportable. Pro forma adjustments reflected in the unaudited pro forma condensed consolidated statements of operations are based on items directly attributable to Ballantyne’s acquisition of Convergent, and that are factually supportable and expected to have a continuing impact on Ballantyne.

 

At this time, Ballantyne is in the early stages of performing detailed valuation analyses to determine the fair values of Convergent’s assets and liabilities. Accordingly, the unaudited pro forma condensed consolidated financial information includes a preliminary allocation of the purchase price based on assumptions and estimates that, while considered reasonable under the circumstances, are subject to change, which may be material. Upon completion of detailed valuation analyses, there may be additional increases or decreases to the recorded book values of Convergent’s assets and liabilities, including, but not limited to trademarks and other intangible assets that will give rise to future amounts of depreciation and amortization expense that are not reflected in the information contained in this unaudited pro forma condensed consolidated financial information. Accordingly, once the final purchase price has been determined and the purchase price allocation has been completed, actual results may differ materially from the information presented in this unaudited pro forma condensed consolidated financial information. Additionally, the unaudited pro forma condensed consolidated statements of operations do not reflect the cost of any integration activities or benefits from the acquisition and synergies that may be derived from any integration activities, both of which may have a material effect on the consolidated results of operations in periods following the completion of the acquisition.

 

Certain amounts in Convergent’s historical balance sheet and statement of operations have been reclassified to conform to Ballantyne’s presentation.

 

2.

Transaction Summary

 

The preliminary allocation of purchase price is based upon management’s best estimate of the fair values of identifiable assets and liabilities of Convergent at the date of acquisition.  The purchase price is subject to further adjustment until all pertinent information regarding the assets, liabilities and deferred taxes are fully evaluated by the Company and independent valuations are complete.  Any adjustment is likely to impact the recorded amount of goodwill. The estimated purchase consideration and preliminary estimate of related excess purchase consideration over book value of net assets acquired are as follows:

 

(thousands)

       

Total consideration

  $ 17,424  
         

Allocated to:

       

Historical net book value of Convergent

  $ 16,953  

Adjustments to recognize assets and liabilities at acquisition date preliminary estimated fair value, except deferred income taxes:

       

Sales type lease receivable

    (237

)

Deferred revenue

    174  

Identifiable intangibles at acquisition date

    258  

Property, plant and equipment

    462

 

Deferred tax impact of preliminary valuation adjustments

    (263

Excess of consideration transferred over the net amount of assets and liabilities recognized (goodwill)

  $ 77  

 

 
 

 

 

3.

Pro Forma Adjustments

 

Adjustments to the pro forma condensed consolidated balance sheet resulting from the net consideration of $17,424 issued in the acquisition of Convergent are as follows:

 

All amounts are shown in thousands.

 

  a) Cash
     
   

Cash and cash equivalents were adjusted for $(103) in acquisition costs Ballantyne incurred after September 30, 2013, including legal, consulting, regulatory, filing and other fees directly related to the acquisition. The tax effect of the acquisition costs is included in the adjustment to deferred income taxes.

     
 

b)

Sales Type Lease Receivable

     
   

An adjustment of $(237) has been made to adjust Convergent’s sales type lease receivable to preliminary estimated fair value.

 

 

c)

Property and Equipment

An adjustment of $462 has been made to record Convergent’s fixed assets to their preliminary estimated fair value of $4,929.

     
 

d)

Income Tax Receivable
     
    An adjustment of $(843) has been made to remove the income tax receivable as all income tax related receivables and payables will remain with prior owner.

 

 

e)

Deposit on Convergent Acquisition

An adjustment of $(17,424) has been made to reflect the application of the deposit paid by Ballantyne on September 30, 2013 to the purchase price for Convergent at closing.

 

 

f)

Goodwill

An adjustment of $77 has been made to record goodwill for Convergent to the preliminary estimated fair value, which is nondeductible for tax purposes.

     
  g) Intangibles Other than Goodwill
     
   

An adjustment of $(909) has been made to remove historical value and $1,167 to record intangibles for Convergent to their preliminary estimated fair value.

 

 (thousands)

 

 Fair Value

 

 

Estimated Useful Life

 

Software

 

$

602

   

5 years

 

Non Compete

 

 

59

 

 

3 years

 

Tradename

 

 

296

 

 

5 years

 

Customer relationships

 

 

210

 

 

10 years

 

Total

 

$

1,167

 

 

N/A

 

 

 

h)

Deferred Taxes

An adjustment of $37 has been recorded to record the tax effects of acquisition costs listed in Note 3(a).

An adjustment of $(263) has been made to record deferred tax assets on the adjusted value of property, equipment, software, tradenames, non-compete and customer relationships.

     
  i) Accounts Payable
     
    An adjustment of $(485) has been recorded to reclassify Convergent’s outstanding checks from accounts payable to cash and cash equivalents, consistent with Ballantyne’s presentation.

 

 

j)

Deferred Revenue

     
    An adjustment of $(174) was recorded to adjust Convergent’s deferred revenue to the fair value at the date of acquisition.

 

 
 

 

 

 

k)

Payable to Related Party

An adjustment of $(11,459) has been recorded to reclassify Convergent borrowings from its former parent, Sony Corporation to equity.

 

 

l)

Stockholders’ Equity

A net adjustments of $66 was recorded as described above to record direct incremental acquisition expenses, depreciation and amortization, net of tax. Historical equity accounts of Convergent were eliminated as a result of the acquisition.

 

Adjustments to the pro forma condensed consolidated statements of operations are as follows:

 

 

m)

Revenue

For purposes of the pro forma condensed consolidated statements of operations for the year ended December 31, 2012 and for the nine months ended September 30, 2013, adjustments of $621 and $466, respectively have been made to reflect Convergent transactions with its former parent company, netted in Cost of Sales.

 

 

n)

Cost of Sales

Other expenses, such as warehouse and engineering, among others of $6,198 and $2,803 for the year ended December 31, 2012 and the nine months ended September 30, 2013, respectively have been reclassified from Convergent’s administrative expenses to cost of sales, consistent with Ballantyne’s presentation.

 

 

o)

Selling expense

For purposes of the pro forma condensed consolidated statements of operations for the year ended December 31, 2012 and for the nine months ended September 30, 2013, adjustments of $2,745 and $1,094, respectively have been made to reclassify Convergent’s selling expense out of administrative expenses, consistent with Ballantyne’s presentation.

 

 

p)

Administrative Expense

For purposes of the pro forma condensed consolidated statement of operations for the nine months ended September 30, 2013 an adjustment of $351 has been made to eliminate direct incremental costs of the acquisition expensed by Ballantyne since they do not represent ongoing costs of the combined entity.

 

 

q)

Depreciation and Amortization

     
    Adjustments of $429 and $422 for the year ended December 31, 2012 and the nine months ended September 30, 2013, respectively have been made to reclassify Convergent’s historical depreciation and amortization to administrative expenses, consistent with Ballantyne’s presentation.
     
   

For purposes of the pro forma condensed consolidated statements of operations for the year ended December 31, 2012 and for the nine months ended September 30, 2013, adjustments have been made to give effect to Convergent’s depreciation on fixed assets and amortization of intangible assets acquired over their preliminary estimated useful lives.  The depreciation and amortization adjustments were $(75) and $(43) for the year ended December 31, 2012, and for the nine months ended September 30, 2013, respectively. Adjustments of $28 and $16 were recorded to adjust the deferred tax liabilities for the depreciation and amortization of property and equipment and intangible adjustments for the year ended December 31, 2012 and for the nine months ended September 30, 2013, respectively.

 

 

r)

Income Tax Expense

     
   

For purposes of the pro forma condensed consolidated statements of operations for the year ended December 31, 2012 and for the nine months ended September 30, 2013, net adjustments of $28 and $(144), respectively, have been made to record federal income tax benefits on the foregoing adjustments at Convergent’s effective rate for each period presented.

 

 

s)

Convergent historical financial statements

     
    Convergent’s historical financial statements were prepared to conform with Ballantyne’s fiscal year as follows:

 

 
 

 

 

   

Convergent Corporation Historical

 

(thousands)

 

Twelve Months Ended
March 31, 2013
(A)

   

Three Months Ended
March 31, 2012

(B)

   

Three Months Ended
March 31, 2013

(C)

   

Twelve Months Ended
December 31, 2012

(A+B-C)

 

Net revenues

  $ 39,517     $ 14,439     $ 12,023     $ 41,933  

Cost of revenues

    29,209       9,555       9,036       29,728  

Gross profit

    10,308       4,884       2,987       12,205  

Selling, general and administrative expenses:

                               

Selling and administrative

    11,550       3,804       2,133       13,221  

Depreciation and amortization

    484       86       141       429  

Total selling, general and administrative expenses

    12,034       3,890       2,274       13,650  

Gain (loss) on the sale/disposal/transfer of assets

    1       -       1       -  

(Loss) income from operations

    (1,725

)

    994       714       (1,445

)

Interest income, net

    192       31       46       177  

(Loss) income before income taxes

    (1,533

)

    1,025       760       (1,268

)

Income tax benefit (expense)

    504       (338

)

    (251

)

    417  

Net (loss) earnings

  $ (1,029

)

  $ 687     $ 509     $ (851

)

 

 

   

Convergent Corporation Historical

 

(thousands)

 

Twelve Months Ended
March 31, 2013
(A)

   

Six Months Ended
September 30, 2013

(B)

   

Nine Months Ended
December 31, 2012

(C)

   

Nine Months Ended
September 30, 2013

(A+B-C)

 

Net revenues

  $ 39,517     $ 13,510     $ 27,460     $ 25,567  

Cost of revenues

    29,209       10,333       20,193       19,349  

Gross profit

    10,308       3,177       7,267       6,218  

Selling, general and administrative expenses:

                               

Selling and administrative

    11,550       5,124       9,364       7,310  

Depreciation and amortization

    484       281       343       422  

Total selling, general and administrative expenses

    12,034       5,405       9,707       7,732  

Gain on the sale/disposal/transfer of assets

    1       -       -       1  

Loss from operations

    (1,725

)

    (2,228

)

    (2,440

)

    (1,513

)

Interest income, net

    192       136       145       183  

Loss before income taxes

    (1,533

)

    (2,092

)

    (2,295

)

    (1,330

)

Income tax benefit

    504       685       754       435  

Net loss

  $ (1,029

)

  $ (1,407

)

  $ (1,541

)

  $ (895

)